• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The expressed L1 proteins of HPV-1, HPV-6, and HPV-11 display type-specific epitopes with native conformation and reactivity with neutralizing and nonneutralizing antibodies.

作者信息

Hines J F, Ghim S J, Christensen N D, Kreider J W, Barnes W A, Schlegel R, Jenson A B

机构信息

Department of Pathology, Georgetown University Medical Center, Washington, DC 20007-2197, USA.

出版信息

Pathobiology. 1994;62(4):165-71. doi: 10.1159/000163906.

DOI:10.1159/000163906
PMID:7537506
Abstract

Previous studies demonstrated that the human papillomavirus (HPV) type 1 L1 protein, expressed in cos cells by an SV40-based vector, displays conformational epitopes characteristic of native virions. In this study, we analyzed the expression of HPV-1, HPV-6, and HPV-11 L1 proteins in order to determine the forms of conformational epitopes expressed by recombinant L1 proteins. Using both immunofluorescence and immunoprecipitation techniques, polyclonal and monoclonal antibodies (MAbs) generated against native HPV-11 virions reacted with expressed L1 proteins of HPV-6 and/or HPV-11, but not HPV-1. Similarly, polyclonal antibodies and MAbs generated against HPV-1 virions reacted with the expressed L1 protein of HPV-1, but not HPV-6 or HPV-11. Of two MAbs that neutralized HPV-11 infection of murine fetal foreskin xenografts, one reacted with the expressed L1 protein of both HPV-6 and HPV-11, and the other reacted with HPV-11 only. A nonneutralizing conformationally dependent MAb reacted with the expressed L1 protein of both HPV-6 and HPV-11. These results demonstrate that expressed HPV L1 proteins retain type-specific, neutralizing, and nonneutralizing conformational epitopes and that cos cells may be utilized to evaluate host immune responses to such epitopes.

摘要

相似文献

1
The expressed L1 proteins of HPV-1, HPV-6, and HPV-11 display type-specific epitopes with native conformation and reactivity with neutralizing and nonneutralizing antibodies.
Pathobiology. 1994;62(4):165-71. doi: 10.1159/000163906.
2
Role of conformational epitopes expressed by human papillomavirus major capsid proteins in the serologic detection of infection and prophylactic vaccination.
Gynecol Oncol. 1994 Oct;55(1):13-20. doi: 10.1006/gyno.1994.1239.
3
HPV-1 L1 protein expressed in cos cells displays conformational epitopes found on intact virions.
Virology. 1992 Sep;190(1):548-52. doi: 10.1016/0042-6822(92)91251-o.
4
Hybrid papillomavirus L1 molecules assemble into virus-like particles that reconstitute conformational epitopes and induce neutralizing antibodies to distinct HPV types.杂交乳头瘤病毒L1分子组装成病毒样颗粒,这些颗粒可重构构象表位并诱导针对不同HPV类型的中和抗体。
Virology. 2001 Dec 20;291(2):324-34. doi: 10.1006/viro.2001.1220.
5
Induction of neutralizing antibodies to papillomaviruses by anti-idiotypic antibodies.抗独特型抗体诱导针对乳头瘤病毒的中和抗体
Virology. 1995 Jul 10;210(2):292-301. doi: 10.1006/viro.1995.1346.
6
Human papillomavirus types 6 and 11 have antigenically distinct strongly immunogenic conformationally dependent neutralizing epitopes.6型和11型人乳头瘤病毒具有抗原性不同的、强烈免疫原性的、构象依赖性中和表位。
Virology. 1994 Nov 15;205(1):329-35. doi: 10.1006/viro.1994.1649.
7
Monoclonal antibodies to HPV-6 L1 virus-like particles identify conformational and linear neutralizing epitopes on HPV-11 in addition to type-specific epitopes on HPV-6.针对人乳头瘤病毒6型L1病毒样颗粒的单克隆抗体,除了能识别6型特异性表位外,还能识别11型人乳头瘤病毒上的构象性和线性中和表位。
Virology. 1996 Oct 15;224(2):477-86. doi: 10.1006/viro.1996.0554.
8
Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies.由单克隆抗体定义的人乳头瘤病毒16型和18型L1病毒样颗粒上的表面构象表位和线性表位
Virology. 1996 Sep 1;223(1):174-84. doi: 10.1006/viro.1996.0466.
9
Mutations on the FG surface loop of human papillomavirus type 16 major capsid protein affect recognition by both type-specific neutralizing antibodies and cross-reactive antibodies.人乳头瘤病毒16型主要衣壳蛋白FG表面环上的突变会影响型特异性中和抗体和交叉反应抗体的识别。
J Med Virol. 2005 Dec;77(4):558-65. doi: 10.1002/jmv.20492.
10
Characterization of neutralizing epitopes within the major capsid protein of human papillomavirus type 33.人乳头瘤病毒33型主要衣壳蛋白中中和表位的特性分析
Virol J. 2006 Oct 2;3:83. doi: 10.1186/1743-422X-3-83.

引用本文的文献

1
Antibody Competition Reveals Surface Location of HPV L2 Minor Capsid Protein Residues 17-36.抗体竞争揭示 HPV L2 次要衣壳蛋白残基 17-36 的表面位置。
Viruses. 2017 Nov 10;9(11):336. doi: 10.3390/v9110336.
2
A novel vaccine for cervical cancer: quadrivalent human papillomavirus (types 6, 11, 16 and 18) recombinant vaccine (Gardasil).一种新型宫颈癌疫苗:四价人乳头瘤病毒(6、11、16 和 18 型)重组疫苗(佳达修)。
Ther Clin Risk Manag. 2008 Feb;4(1):65-70. doi: 10.2147/tcrm.s856.
3
Therapeutic immunisation of rabbits with cottontail rabbit papillomavirus (CRPV) virus-like particles (VLP) induces regression of established papillomas.
用棉尾兔乳头瘤病毒(CRPV)病毒样颗粒(VLP)对兔子进行治疗性免疫可使已形成的乳头瘤消退。
Virol J. 2008 Mar 20;5:45. doi: 10.1186/1743-422X-5-45.
4
Immunomanipulative strategies for the control of human papillomavirus associated cervical disease.用于控制人乳头瘤病毒相关宫颈疾病的免疫调控策略
Immunol Res. 1997;16(4):387-400. doi: 10.1007/BF02786401.
5
Human papillomavirus infection.
BMJ. 1996 Mar 2;312(7030):522-3. doi: 10.1136/bmj.312.7030.522.